Home / Ketamine / United States
US ATC N01AX03 · updated 2 Nov 2026
Ketamine shortage in United States
Is there a Ketamine shortage in United States?
Yes. As of 2 Nov 2026, 1 Ketamine product is reported short in United States, the first since 7 Nov 2025. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Ketamine Hydrochloride, Injection, 500 mg/5mL (100 mg/mL); Multiple Dose Glass Fliptop Vial Novaplus (NDC 0409-0040-10) discontinuation | Pfizer Inc. | 7 Nov 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).